blood pressure effect
Recently Published Documents


TOTAL DOCUMENTS

29
(FIVE YEARS 4)

H-INDEX

9
(FIVE YEARS 0)

Nutrients ◽  
2021 ◽  
Vol 13 (12) ◽  
pp. 4560
Author(s):  
Alicia Gea Cabrera ◽  
Pablo Caballero ◽  
Carmina Wanden-Berghe ◽  
María Sanz-Lorente ◽  
Elsa López-Pintor

Workplace health interventions are essential to improve the health and well-being of workers and promote healthy lifestyle behaviours. We carried out a systematic review, meta-analysis and meta-regression of articles measuring the association between workplace dietary interventions and MetS risk. We recovered potentially eligible studies by searching MEDLINE, the Cochrane Library, Embase, Scopus and Web of Science, using the terms “Metabolic syndrome” and “Occupational Health”. A total of 311 references were retrieved and 13 documents were selected after applying the inclusion and exclusion criteria. Dietary interventions were grouped into six main types: basic education/counselling; specific diet/changes in diet and food intake; behavioural change/coaching; physical exercise; stress management; and internet/social networks. Most programmes included several components. The interventions considered together are beneficial, but the clinical results reflect only a minimal impact on MetS risk. According to the metaregression, the interventions with the greatest impact were those that used coaching techniques and those that promoted physical activity, leading to increased HDL (effect size = 1.58, sig = 0.043; and 2.02, 0.015, respectively) and decreased BMI (effect size = −0.79, sig = −0.009; and −0.77, 0.034, respectively). In contrast, interventions offering information on healthy habits and lifestyle had the contrary effect, leading to increased BMI (effect size = 0.78, sig = 0.006), systolic blood pressure (effect size = 4.85, sig = 0.038) and diastolic blood pressure (effect size = 3.34, sig = 0.001). It is necessary to improve the efficiency of dietary interventions aimed at lowering MetS risk in workers.


2021 ◽  
Vol 77 (18) ◽  
pp. 840
Author(s):  
David E. Lanfear ◽  
Hongsheng Gui ◽  
Bashar Hannawi ◽  
Thomas Connolly ◽  
Jia Li ◽  
...  

2019 ◽  
Vol 21 (3) ◽  
pp. 438-439
Author(s):  
Tibor Fülöp ◽  
Karim Soliman ◽  
Mihály Tapolyai

Author(s):  
Michael Young ◽  
Karen Jansen ◽  
Tim Gould ◽  
Coralynn Sack ◽  
Laura Hooper ◽  
...  

2016 ◽  
Vol 36 (1) ◽  
pp. 107-108 ◽  
Author(s):  
Caroline Lamarche ◽  
Maude Pichette ◽  
Denis Ouimet ◽  
Michel Vallée ◽  
Robert Bell ◽  
...  

The aim of our study was to evaluate the efficacy and bioavailibility of a commonly used oral furosemide dose (500 mg) compared to a 250 mg intravenous (IV) dose in PD patients with significant residual renal function (urine volume > 100 mL). We also evaluated the immediate blood pressure effect in these patients. The data were obtained from a study we performed for the homologation of a 500-mg dose of furosemide by Health Canada.


2015 ◽  
Vol 6 (11) ◽  
pp. 3479-3489 ◽  
Author(s):  
Mar Quiñones ◽  
Maria Margalef ◽  
Anna Arola-Arnal ◽  
Begoña Muguerza ◽  
Marta Miguel ◽  
...  

We studied the short-term antihypertensive effect of flavan-3-ols (−)-epicatechin, (+)-catechin and (−)-catechin, in spontaneously hypertensive rats (SHR).


2014 ◽  
pp. 175-180
Author(s):  
James P. Howard ◽  
Matthew J. Shun-Shin ◽  
Darrel P. Francis

2014 ◽  
Vol 8 (4) ◽  
pp. 129
Author(s):  
B. Spronck ◽  
A. De Lepper ◽  
M. Alivon ◽  
P. Boutouyrie ◽  
K. Reesink

Sign in / Sign up

Export Citation Format

Share Document